Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alaa A Alotaibi"'
Autor:
Mohammed N Aljehani, Ziyad I Alshehri, Faisal A Alharbi, Yaser T Balbaid, Abdullah M Wali, Alaa A Alotaibi
Publikováno v:
Cureus. 14(12)
Background Multiple sclerosis (MS) is an immune-mediated inflammatory disease that attacks myelinated axons in the central nervous system, destroying the myelin and axon to varying degrees and producing significant physical disability. So far, many s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::940862a1ff5ae8253af2d94fa1600014
https://pubmed.ncbi.nlm.nih.gov/36618495
https://pubmed.ncbi.nlm.nih.gov/36618495
Autor:
Eman Abbas Zaher, Wafa Romaih Alromaih, Alaa saad Alotaibi, Anwar Abdullah Almughairy, Amaal Abdullah Alqarfan, Zainab Ayesh Alheji
Publikováno v:
World Family Medicine Journal /Middle East Journal of Family Medicine.
Objectives: Under-reporting despite high prevalence of domestic violence (DV) indicates a serious gap in identifying and reporting domestic violence. Therefore this study aims to assess the readiness of health care workers in identifying and handling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7da5f90d444c30398aa0a87d2a571da9
https://doi.org/10.5742/mewfm.2022.9525095
https://doi.org/10.5742/mewfm.2022.9525095
Publikováno v:
CNS Drugs. 35:385-402
Fingolimod (Gilenya) received regulatory approval from the US FDA in 2010 as the first-in-class sphingosine 1-phosphate (S1P) receptor (S1PR) modulator and was the first oral disease-modifying therapy (DMT) used for the treatment of the relapsing for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fafa090f732b8cb7b882e021688f3125
https://doi.org/10.1007/s40263-021-00798-w
https://doi.org/10.1007/s40263-021-00798-w
Publikováno v:
CNS drugs. 35(4)
Fingolimod (Gilenya) received regulatory approval from the US FDA in 2010 as the first-in-class sphingosine 1-phosphate (S1P) receptor (S1PR) modulator and was the first oral disease-modifying therapy (DMT) used for the treatment of the relapsing for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b322a08d2edc4cbbe6295e238c8ed84e
https://pubmed.ncbi.nlm.nih.gov/33797705
https://pubmed.ncbi.nlm.nih.gov/33797705